Cytosorbents Aktie

0,5540 EUR -0,0460 EUR -7,67 %

29.12.2025

BMN

0,6702 USD -0,0147 USD -2,15 %

29.12.2025

BTT

Cytosorbents jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.36,28 Mio. EUR

Div. Rendite0,00%

WKNA12GDU

ISINUS23283X2062

SymbolCTSO

Cytosorbents Aktien News

Sortieren:Datum Meistgelesen

10.12.25PR NewswireCytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

17.11.25PR NewswireUpdated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

13.11.25PR NewswireCytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

WerbungCytosorbents-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

11.11.25PR NewswireCytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

30.10.25PR NewswireCytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

28.10.25PR NewswireIn Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

29.09.25PR NewswireCytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

16.09.25PR NewswireCytoSorbents Provides DrugSorb-ATR Regulatory Update

08.09.25PR NewswireCytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

05.09.25PR NewswireCytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

20.08.25PR NewswireCytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

07.08.25PR NewswireCytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

31.07.25PR NewswireCytoSorbents Leads a New Era in Sepsis Treatment

29.07.25PR NewswireCytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

02.07.25PR NewswireCytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

24.06.25PR NewswireCytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

29.05.25PR NewswireCytoSorbents to Participate at the Jefferies Global Healthcare Conference

22.05.25PR NewswireCytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

14.05.25PR NewswireCytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

01.05.25PR NewswireCytoSorbents Provides Regulatory Update for DrugSorb-ATR

29.04.25PR NewswireCytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

21.04.25PR NewswireCytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

17.04.25PR NewswireCytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

14.04.25PR NewswireCytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

31.03.25PR NewswireCytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

21.03.25PR NewswireCytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

30.07.24GlobeNewswireCytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

31.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

23.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

06.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

29.12.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

14.08.23PR NewswireCytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

27.02.23PR NewswireCytoSorbents to Present at the Cowen 43rd Annual Health Care Conference

24.02.23PR NewswireCytoSorbents to Report Fiscal 2022 Operating and Financial Results

31.01.23PR NewswireCytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue

23.01.23PR NewswireCytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial

17.01.23PR NewswireCytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs

29.12.22PR NewswireCytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement

Cytosorbents News

Cytosorbents News: auf dieser Seite finden Sie alle Cytosorbents News und Nachrichten zur Cytosorbents Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Cytosorbents News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Cytosorbents News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.